News Release

Alarmingly high rate of antibiotics prescribed without evidence of office visit

Analysis of antibiotic prescriptions dispensed to Medicaid recipients finds that more than a quarter were not associated with a clinic visit, raising questions about the effectiveness of efforts to curb inappropriate prescribing

Peer-Reviewed Publication

Brigham and Women's Hospital

Boston, MA -- A new study highlights a key area that might be missed by current efforts to ensure appropriate antibiotic use. A wide range of clinical policies aim to reduce the prescribing of antibiotics for illnesses that are not caused by a bacterial infection. These efforts are intended to help decrease the rate of antibiotic prescribing in the U.S., which is about double that of many other countries. However, such efforts may miss antibiotics that providers prescribe outside of clinical visits. Investigators from Brigham and Women's Hospital evaluated hundreds of millions of antibiotic prescriptions filled by Medicaid recipients over 10 years and found 28 percent were not associated with a clinic visit and another 17 percent were associated with visits with no documented infection-related diagnosis. Results are published in the February issue of Health Affairs.

"If we're thinking about how to improve antibiotic use, we need to understand the context in which antibiotics are being prescribed," said lead author Michael Fischer, MD, MS, a physician in the Brigham's Division of Pharmacoepidemiology and Pharmacoeconomics and an associate professor of Medicine at Harvard Medical School. "If prescribing is taking place outside of an office visit, most of the approaches we're taking to combat antibiotic overuse will miss those completely."

To capture these blind spots, Fischer and colleagues used national Medicaid claims data from 2004 to 2013. They identified 298 million antibiotic prescriptions that had been filled during this time for 53 million patients. The researchers used the Medicaid data to determine whether patients had made a clinic visit in the seven days prior to filling the antibiotic prescription and when there was a visit they checked whether the billing diagnosis specified an infection as the cause for the visit. The team found that 28 percent of the filled antibiotic prescriptions had no claims for a clinician encounter in the seven previous days and another 17 percent were not associated with a visit for an infection-related diagnosis.

"It seems inappropriate that 17 percent of antibiotic prescriptions were given without an infection-related diagnosis, and it's concerning that nearly one in five antibiotics are prescribed without a clear rationale," said senior study author Jeffrey Linder, MD, MPH, chief of general internal medicine and geriatrics in the department of medicine at Northwestern University Feinberg School of Medicine.

The authors acknowledge that a critical question remains: What occurred clinically in the many cases when antibiotic prescriptions were dispensed without an office visit?

"Since our analyses were based on claims data, we don't have access to medical records to determine what interactions took place between patients and prescribing clinicians. We assume that most of these prescriptions were associated with a telephone interaction, although some communication may have occurred over email, via web portals or in informal, uncaptured visits. Most of these encounters would be blind spots for the interventions designed to improve antibiotic use."

Fischer notes that it will be important for future research to use clinical data to examine outcomes for patients who are prescribed antibiotics outside of office visits, adding that future interventions to improve the quality of antibiotic care should be designed with the study's findings in mind so that this large proportion of prescriptions is not missed.


Funding for this work was provided by the Agency for Healthcare Research and Quality (R01HS024930).

Paper cited: Fischer, MA et al. "Non-Infection-Related and Non-Visit-Based Antibiotic

Prescribing is Common Among Medicaid Patients" Health Affairs DOI: 10.1377/hlthaff.2019.00545

Brigham Health, a global leader in creating a healthier world, consists of Brigham and Women's Hospital, Brigham and Women's Faulkner Hospital, the Brigham and Women's Physicians Organization and many related facilities and programs. With more than 1,000 inpatient beds, approximately 60,000 inpatient stays and 1.7 million outpatient encounters annually, Brigham Health's 1,200 physicians provide expert care in virtually every medical and surgical specialty to patients locally, regionally and around the world. An international leader in basic, clinical and translational research, Brigham Health has nearly 5,000 scientists, including physician-investigators, renowned biomedical researchers and faculty supported by over $700 million in funding. The Brigham's medical preeminence dates back to 1832, and now, with 19,000 employees, that rich history is the foundation for its commitment to research, innovation, and community. Boston-based Brigham and Women's Hospital is a teaching affiliate of Harvard Medical School and dedicated to educating and training the next generation of health care professionals. For more information, resources, and to follow us on social media, please visit

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.